New Delhi, March 30 Alembic Pharmaceuticals Ltd announced on Monday that it has received final approval from the US health regulator for its generic version of Paroxetine extended-release tablets, indicated for various mental health conditions.The approval from the US Food & Drug...
New Delhi, February 16 Drug firm Lupin announced on Monday that it has signed a licensing and supply agreement with Spektus Pharma to commercialize the novel antidepressant DeslaFlex in Canada.The strategic partnership combines Lupin's strong commercial presence in Canada and Spektus's...